Dorphyll Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-07-2024
- Paid Up Capital ₹ 1.00 M
as on 12-07-2024
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Dorphyll Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Hitesh Madhavkumar and Shilpa serve as directors at the Company.
- CIN/LLPIN
U24299KA2021PTC149000
- Company No.
149000
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jul 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Dorphyll Healthcare Private Limited offer?
Dorphyll Healthcare Private Limited offers a wide range of products and services, including Antibiotic Tablets & Capsules, Cefixime Ofloxacin Tablets, Azithromycin Tablets, Cefixime Tablet, Cough Syrup, Antibacterial Drugs, Ofloxacin Ornidazole Tablets, Cefixime and Lactic Acid Bacillus Tablets, Pantoprazole Drugs, Pantoprazole Tablets.
Who are the key members and board of directors at Dorphyll Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hitesh Madhavkumar  | Director | 01-Jul-2021 | Current |
| Shilpa | Director | 01-Jul-2021 | Current |
Financial Performance of Dorphyll Healthcare.
Enhance accessibility to Dorphyll Healthcare's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dorphyll Healthcare?
Unlock access to Dorphyll Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Surgeway Biosciences Private LimitedActive 1 year 7 monthsHitesh Madhavkumar and Shilpa are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dorphyll Healthcare?
Dorphyll Healthcare has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dorphyll Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dorphyll Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
